论文部分内容阅读
我院自2008年起采用达珂联合化疗对高危MDS患者进行治疗,取得可较为理想的治疗效果,报告如下。1资料与方法1.1临床资料选择2008年5月至2014年12月期间我院诊治的54例高危MDS患者作为实验对象,根据治疗方案分为观察组26例和对照组28例,观察组中男15例,女11例,年龄30~83岁,平均(60.52±4.81)岁,病程8~26.5个月;其中
In our hospital since 2008, DaCe combination chemotherapy for high-risk patients with MDS treatment, and achieved satisfactory treatment, the report is as follows. 1 Materials and Methods 1.1 Clinical data Select 54 cases of high-risk MDS patients treated in our hospital from May 2008 to December 2014 as the experimental subjects, according to the treatment plan was divided into observation group of 26 cases and control group of 28 cases, the observation group male 15 cases and 11 females, aged 30-83 years, with an average of (60.52 ± 4.81) years and a duration of 8 to 26.5 months